Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-LY trial published in the Journal of the American College of Cardiology.

New ultra-thin drug-eluting stents (DES) are associated with a 16 percent reduction in target lesion failure (TLF) at one year compared to thicker-strut, second-generation DES, according to a meta-analysis published June 26 in Circulation.

School programs that provide fresh fruits and vegetables and limit the availability of sugar-sweetened beverages (SSBs) could prevent an estimated 22,383 deaths due to cardiometabolic disease each year in the U.S., researchers calculated in a study published July 6 in PLOS One.

In the era of the Quadruple Aim, there’s no shortage of studies, media coverage and commentary on how our healthcare systems may be overusing resources.

SAN DIEGO, July 9, 2018 — Companion Medical, a leader in the development of advanced technology to improve diabetes care, has received FDA clearance for the Android version of its InPen™ app, clearing the way for release of the first smart pen system for Android users.

About two-thirds of patients older than 65 who experience a myocardial infarction die within eight years, according to a new study—and nearly half die in that timeframe even if they receive percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery.

In a study of nearly 25,000 children, those whose mothers adhered to five healthy lifestyle factors carried a 75 percent lower risk of obesity than children whose mothers had none of those habits.

Norepinephrine seemed to be a safer vasopressor than epinephrine for patients with cardiogenic shock following acute myocardial infarction, according to a small randomized trial conducted in France. Significantly more patients given epinephrine developed refractory cardiogenic shock, causing the study to be stopped early.

New research published in the Journal of the American Medical Association suggests an association between black postmenopausal women who are carriers of apolipoprotein L1 (APOL1) genotypes and hospitalizations for heart failure with preserved ejection fraction (HFpEF). The findings, however, do not support an association between APOL1 genotypes and coronary heart disease, stroke or mortality.

Patients with stable coronary artery disease (CAD) who were evaluated with either cardiac magnetic resonance (CMR) or conventional angiography showed similar rates of myocardial infarction and death at one and three years of follow-up, according to a study published in JACC: Cardiovascular Imaging.